National Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer

Project Details

Short titleNational Lung Matrix Trial: Multi-drug, genetic marker-directed, non-comparative, multi-centre, multi-arm phase II trial in non-small cell lung cancer
StatusActive
Effective start/end date1/10/16 → 31/10/23

Funding

  • Cancer Research Uk
View all
View less

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint

  • The National Lung Matrix Trial of personalized therapy in lung cancer

    Middleton, G., Fletcher, P., Popat, S., Savage, J., Summers, Y., Greystoke, A., Gilligan, D., Cave, J., O’rourke, N., Brewster, A., Toy, E., Spicer, J., Jain, P., Dangoor, A., Mackean, M., Forster, M., Farley, A., Wherton, D., Mehmi, M., Sharpe, R., & 7 othersMills, T. C., Cerone, M. A., Yap, T. A., Watkins, T. B. K., Lim, E., Swanton, C. & Billingham, L., 30 Jul 2020, In: Nature. 583, 7818, p. 807-812 6 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    14 Citations (Scopus)
    323 Downloads (Pure)